Javascript must be enabled to continue!
Abstract 453: The role of centrosome amplification in HCC
View through CrossRef
Abstract
Centrosome is the major microtubule organizing center (MTOC) in mammalian cells which maintain cell polarity, organization of microtubules and regulate cell cycle progression. In normal cells, centrosome duplication cycle is tightly coupled with cell cycle, DNA synthesis, mitosis as these event were controlled by parallel pathways. Centrosomal defect is reported in numerous type of solid and hematologic malignancy, both structurally (enlarged PCM, string-like etc) and numerically (<2 or >=3). Centrosome amplification (CA, n>=3) is the most commonly reported. CA is casually linked to chromosomal instability (CIN), tumor-initiation, advanced tumor stage and chemo-resistance. CA arises through multiple distinct but non-redundant mechanisms in tumor, for example, aberrant cell cycle, hypoxia, and chemotherapy. Recently studies suggest CA might not be responsible for HCC initiation. Yet, around 90% of HCC cells carry certain degree of CA. It is associated with p53 mutation and tumor-aneuploidy but no other clinicopathological features. The role of CA in HCC progression deserve a more comprehensive study. To investigate the role of CA in HCC, first, we use CA20, an expression signature-score includes centrosomal structural genes and genes results in CA when dyregulated. We use CA20 as surrogate marker to evaluate the clinical outcome of CA in HCC from GEO datasets. CA carrying HCC was found to have poor overall survival and larger tumor size. Next, we developed several inducible PLK4 overexpressing HCC cell line. Preliminary data shown that PLK4 overexpression concomitantly leaded to centrosome over-duplication in HCC cell lines. Functionally, PLK4 overexpression resulted in increased cell migration, but retarded growth rate in p53+/+ HCC cells. Furthermore, we identified another cell cycle-related kinase - Aurora A, as a novel interacting partner of PLK4 suggest that these kinases work together to promote malignant transformation.
Citation Format: Sai Fung Yeung, Yick Pang Ching. The role of centrosome amplification in HCC [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 453.
Title: Abstract 453: The role of centrosome amplification in HCC
Description:
Abstract
Centrosome is the major microtubule organizing center (MTOC) in mammalian cells which maintain cell polarity, organization of microtubules and regulate cell cycle progression.
In normal cells, centrosome duplication cycle is tightly coupled with cell cycle, DNA synthesis, mitosis as these event were controlled by parallel pathways.
Centrosomal defect is reported in numerous type of solid and hematologic malignancy, both structurally (enlarged PCM, string-like etc) and numerically (<2 or >=3).
Centrosome amplification (CA, n>=3) is the most commonly reported.
CA is casually linked to chromosomal instability (CIN), tumor-initiation, advanced tumor stage and chemo-resistance.
CA arises through multiple distinct but non-redundant mechanisms in tumor, for example, aberrant cell cycle, hypoxia, and chemotherapy.
Recently studies suggest CA might not be responsible for HCC initiation.
Yet, around 90% of HCC cells carry certain degree of CA.
It is associated with p53 mutation and tumor-aneuploidy but no other clinicopathological features.
The role of CA in HCC progression deserve a more comprehensive study.
To investigate the role of CA in HCC, first, we use CA20, an expression signature-score includes centrosomal structural genes and genes results in CA when dyregulated.
We use CA20 as surrogate marker to evaluate the clinical outcome of CA in HCC from GEO datasets.
CA carrying HCC was found to have poor overall survival and larger tumor size.
Next, we developed several inducible PLK4 overexpressing HCC cell line.
Preliminary data shown that PLK4 overexpression concomitantly leaded to centrosome over-duplication in HCC cell lines.
Functionally, PLK4 overexpression resulted in increased cell migration, but retarded growth rate in p53+/+ HCC cells.
Furthermore, we identified another cell cycle-related kinase - Aurora A, as a novel interacting partner of PLK4 suggest that these kinases work together to promote malignant transformation.
Citation Format: Sai Fung Yeung, Yick Pang Ching.
The role of centrosome amplification in HCC [abstract].
In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL.
Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 453.
Related Results
Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
<p><strong><span dir="ltr" role="presentation">1. Introduction</span></strong&...
Evaluation of AFP, AFP-L3%, and DCP in the diagnosis and after surgery prognosis of HCC
Evaluation of AFP, AFP-L3%, and DCP in the diagnosis and after surgery prognosis of HCC
Abstract
Background
To investigate the prognostic value of alpha-fetoprotein (AFP), ratio (AFP-L3%), and Des-γ-carboxyprothrombin (DCP) in the diagnosis and surgical resec...
Outcomes after curative treatment for cryptogenic cirrhosis‐associated hepatocellular carcinoma satisfying the Milan criteria
Outcomes after curative treatment for cryptogenic cirrhosis‐associated hepatocellular carcinoma satisfying the Milan criteria
AbstractBackground and Aim: The prognosis of cryptogenic cirrhosis‐associated hepatocellular carcinoma (CC‐HCC) was reported to be poor because many of them were discovered at the...
Abstract 4015: Amplification of GEP at chromosome 17q21 and its overexpression in human liver cancer.
Abstract 4015: Amplification of GEP at chromosome 17q21 and its overexpression in human liver cancer.
Abstract
Amplification of GEP at chromosome 17q21 and its overexpression in human liver cancer
Hermann M.K. Yung, Wallace C.W. Yip, Phyllis F.Y. Cheun...
Setting the Record Straight: Utility and Outcomes in Patients With
HCV
Related
HCC
Setting the Record Straight: Utility and Outcomes in Patients With
HCV
Related
HCC
ABSTRACT
The effectiveness of direct acting antiviral (DAA) therapy in patients with active hepatocellular carcinoma (HCC) is poorly defined....
Catalytic growth in a shared enzyme pool ensures robust control of centrosome size
Catalytic growth in a shared enzyme pool ensures robust control of centrosome size
Abstract
Accurate regulation of centrosome size is essential for ensuring error-free cell division, and dysregulation of centrosome size has been linked to various pathologies, inc...
Catalytic growth in a shared enzyme pool ensures robust control of centrosome size
Catalytic growth in a shared enzyme pool ensures robust control of centrosome size
Accurate regulation of centrosome size is essential for ensuring error-free cell division, and dysregulation of centrosome size has been linked to various pathologies, including de...
Exosomal miR-452-5p Induce M2 Macrophage Polarization to Accelerate Hepatocellular Carcinoma Progression by Targeting TIMP3
Exosomal miR-452-5p Induce M2 Macrophage Polarization to Accelerate Hepatocellular Carcinoma Progression by Targeting TIMP3
Background. Hepatocellular carcinoma (HCC) cell-derived exosomes have shown effects on inducing M2 macrophage polarization and promoting HCC progression. MiR-452-5p was reported by...

